Bevacizumab (Avastin) IV Solution from China
Bevacizumab (Avastin) is a humanized monoclonal antibody that blocks vascular endothelial growth factor (VEGF), used in treating colorectal and lung cancers. It is presented as an IV solution in measured-dose vials for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. The product regulates immunological processes via angiogenesis inhibition.
Duty Rate — China → Canada
0%
Import Tips
• Ensure vials are labelled with exact dosage for retail sale to meet tariff item requirements
• Keep batch records and certificates of analysis for CBSA inspection
• Verify if the product requires a Health Canada establishment licence